Hipertrófiás kardiomiopátia: vizsgálatok itt: Spanyolország
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in SpanyolországStudy of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
- Where
- Majadahonda
- Életkor
- 6 év and over
- People
- 26 worldwide
- Run by
- Lexeo Therapeutics
See details and how to joinNCT07721025 · EU 2025-524970-40-00 - 2. fázisTaking peopleA randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
- Where
- A Coruña, Alicante, Barcelona, Granada, L'hospitalet De Llobregat, Madrid, Majadahonda, Murcia, Palma, Salamanca, Sevilla, Valencia, Vigo
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 - 2. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Where
- A Coruña, Barcelona, El Palmar, Granada, Madrid, Palma de Mallorca, Salamanca, Seville, Valencia, Vigo
- Életkor
- 18 év and over
- People
- 165 worldwide
- Run by
- Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614 - 2/3. fázisTaking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- A Coruña, Barcelona, Madrid, Majadahonda, Málaga, Murcia, Palma, Salamanca, Sevilla, Vigo
- Életkor
- 18 év to 85 év
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - No phaseTaking peopleA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Burgos, El Palmar, Madrid, Majadahonda, Málaga, Oviedo, Palma de Mallorca
- Életkor
- 18 év and over
- People
- 1700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705